1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow 1-Deoxynojirimycin: new trials by email Literature Review of 1-Deoxynojirimycin trials Research Report on 1-Deoxynojirimycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Drug-drug Interaction Study duvoglustat, rhGAA - Pompe Disease | Phase 2 | Completed | Amicus Therapeutics | 25 | 2011-10-31 | 2025-06-26 |
| Study to Evaluate the Safety of AT2220 (Duvoglustat) in Pompe Disease Duvoglustat - Pompe Disease | Phase 2 | Terminated | Amicus Therapeutics | 3 | 2008-12-08 | 2025-09-11 |
Glycogen Storage Disease Type II (2)
United States (2) · Canada (1) · France (1) · United Kingdom (1)